Workspan Daily article Strategies to Deliver Diabetes Support and Solutions for Employees, Workspan Daily article Fifty-one percent of employers in a recent benefits study cited glucagon-like peptide-1 (GLP-1) diabetes and weight-loss medications as the top driver of prescription drug spend, surpassing even cancer and autoimmune treatments
Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis
Conclusion In addition to the well-established role of GLP-1 to improve glucose homeostasis, GLP-1R agonism has beneficial effects on body weight reduction
A Balanced Approach to Your Health As a dietitian, I always advocate for a food-first approach to nutrition
Ezras role in proactive health At Ezra, we believe that taking a science-first approach is the most reliable path to lasting health outcomes
It enhances insulin secretion, yes, but it also appears to improve fat tissue function, reduce inflammation in adipose tissue, and potentially improve how the body partitions nutrients between fat storage and energy use
.jpg)
